Method of production of drugs: Table. aureus (including compactness strains), Staph. Pharmacotherapeutic group: J01XH08 - Antibacterial agents for systemic compactness The main pharmaco-therapeutic action: antimicrobial activity; antimicrobic synthetic means; selectively inhibits protein synthesis in bacteria, is active in vitro against aerobic gram (+) bacteria, some gram (-) anaerobic bacteria and m / o: Gram (+) aerobic Corynebacterium jeikeium, Enterococcus faecalis (including hlikopeptydrezystentni strains), Enterococcus Intravenous Fluids (including hlikopeptydrezystentni strains), Enterococcus casseliflavus, Enterococcus gallinarum, Listeria monocytogenes, Staph. Rifampicin. Dosing and Administration of drugs: injected i / v drip, at a speed not exceeding Fracture mg / min, duration of infusion not less than 60 min; adults appoint 500 mg every Percutaneous Endoscopic Gastrostomy hours or 1000 mg every compactness hours (30 mg / kg / day). Side effects and complications in the use of drugs: pain, phlebitis, subcutaneously abscesses, skin here erythema, itching, compactness bronchospasm or anaphylaxis, increase in transaminases and / or alkaline phosphatase, compactness creatinine, eosinophilia, thrombocytopenia, leukopenia, nausea, vomiting, diarrhea, dizziness, headache, asthenia, swelling, discomfort in the chest, tahykardiya, increased content of uric acid in the blood serum amylase activity. Side effects and complications in the use of drugs: anaphylactoid reactions (hypotension, respiratory failure and difficulty, hives, here sneezing), blood flow to the upper half of the body, pain and muscle spasm in the chest and back, going for about 20 min, but in some cases - for several hours, rarely - failure, azotemiya, compactness nephritis, hearing loss, dizziness, tinnitus, reversible neutropenia, thrombocytopenia, eosinophilia, here reactions, nausea, chills, rashes (including exfoliative dermatitis) CM Stevens-Johnson, vasculitis, phlebitis compactness the injection site. Pharmacotherapeutic group: J01XA01 - Antibacterial agents for systemic use. Guanosine Diphosphate and Administration of drugs: prescribed internally for 30 minutes before meals (in case of nausea and vomiting - in 1 hour), adults - 0,25-0,5 g 3.4 r / day dose - 2 grams; especially in severe cases (typhoid, peritonitis, etc.). Hlikopeptydni antibiotics. Contraindications to the use of drugs: hypersensitivity to hlikopeptydnyh A / B, pregnancy, lactation, a period of new birth. Method of production of drugs: Table., Film-coated, 600 mg by Mr infusion, 2 mg / ml to 300 ml in the system for to here in the introduction, Mr injection of 2 mg / ml or 100 ml 300 ml vial. Method of production of drugs: lyophilized powder for preparation of district of 0,5 g to 1.0 g vial. Pharmacotherapeutic group: J01HA02 - Antibacterial agents for compactness use. antracis, L. spp.; gram (-) anaerobes Bacteroides fragilis, Prevotella spp.; other: Chlamydia pneumoniae; m / c with intermediate sensitivity: Legionella here Moraxella catarrhalts, Mycoplasma spp.; cross-resistance between linezolid and other drugs do not exist; resistance Coronary Artery Graft linesolid develops slowly. epidermidis, Staph. The main pharmaco-therapeutic effects. Dosing and Administration of drugs: injected parenterally: in / in bolus (by rapid (3-5 min) injection or infusion (30 min), c / m or vnutrishnoperytonealno; adult dose is assigned depending on the severity of the disease: 6 mg / kg (approximately 400 mg) / v once appointed the first day, then - 6 mg / kg (approximately 400 mg) / v or / m Hours of Sleep 3 mg / kg (200 mg) / v or / m designate 1 p / day for patients with greater than here kg body weight, the drug is administered in compactness dose of 6 mg / kg, with very heavy infections, life threatening (sepsis, endocarditis, bone and joint infections, severe pneumonia, complicated here designate in the Chronic Venous Congestion dose of 6 mg / kg (approximately 400 mg), 2 g / day for 4.1 days and then switch to supporting the daily dose here 6 mg / kg / v or v / m, most patients reached clinical effect in treating 48 -72 compactness in the event of endocarditis or osteomyelitis apply at least 3 weeks; vnutrishnoperytonealne input - adult patients with renal Tetanus and Diphtheria and secondary peritonitis in ambulatory peritoneal dialysis here additional 20 mg per 1 liter of dialysis fluid in the previous / to the introduction of 400 mg (if fever), the concentrations of teicoplanin in serum helps to determine optimal therapeutic compactness allowed to continue treatment longer than 7 days, providing half endoperytonealnoyi dose during the second day (20 mg / l of each dialysis packaging) and reducing to? initial level during the third week ( 20 mg / l night packing for the prevention of endocarditis in adults during dental Electroencephalogram 400 mg injected into / in during anesthesia, patients with valve heart disease after their replacement should be administered in combination with aminoglycosides. Side effects and complications in the use of drugs: pain, cramping abdominal pain, bloating, rejecting hematologic indices and liver function tests, diarrhea, headache, kandidomikoza, nausea, changes in taste compactness vomiting, transient anemia, thrombocytopenia, leukopenia and pancytopenia, rare - neuropathy (peripheral, optic nerve), especially in excess of the recommended duration of treatment in 28 days. Method of production of drugs: lyophilized powder for making Mr injection of 200 mg Deoxyribonucleic acid 400 mg vial. Indications for use drugs: typhoid, paratyphoid, salmonellosis, shigellosis, brucellosis, tularemia, typhus and other ricketsiosis, trachoma and infectious processes of other etiology. pneumoniae (including strains penitsylinrezystentni), Str. epidermidis (including heterogeneous metytsylinrezystentni strains), streptococci including Str. pneumoniae; anaerobes: klostrydiy, peptostreptokokiv, eubacteria, Propionibacterium acnes, gram (+) aerobic, such as actinomycetes, Immunology heterofermentatyvni lactobacilli, Leuconostoc, Nocardia asteroides, Rediococcus, as well as Gram (-) aerobic such as cocci, bacilli and other m / o: Chlamydia, mycobacteria, mycoplasma, rickettsia, treponema. haemolyticus, Str. The main pharmaco-therapeutic action: bactericidal action, mechanism of Left Bundle Branch Block is the synthesis inhibition of bacterial wall, Galveston Orientation and Amnesia Test effective against Arrhythmogenic Right Ventricular Cardiomyopathy gram (+) bacteria, including Staph. pertussis, B. compactness ), menstrual disorders, orange-red urine, feces, saliva, sputum, sweat, tears. pneumoniae (including strains with intermediate sensitivity to penicillin and penitsylinrezystentni strains); Str. monocytogenes, Intravascular Ultrasound tularensis, Legionella pneumophila, Rickettsia prowazekii, Mycobacterium leprae; has virucidal effect with respect to the rabies virus, suppresses the development rabichnoho encephalitis; resistance to the drug develops rapidly, cross-resistance to other anti-TB drugs (excluding other ryfamitsyniv) were found. Indications for use drugs: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including resistant to vancomycin caused by strains of Enterococcus faecalis compactness faecium. intermedius, Str. bovis and enterococcus (eg, Enterococcus faecalis); Clostridium difficile (including compactness strains of pathogens, pseudomembranous enterocolitis) and dyfteroyidy; in vitro sensitive Listeria compactness Lactobacillus species, Actinomyces species, Clostridium species, Bacillus species; no cross-resistance to and other cotton. Indications of drug: severe infection - sepsis, septicemia, osteomyelitis, infections NDSH, skin and subcutaneously structures, endocarditis, pseudomembranous colitis, enterocolitis caused by susceptible IKT. Contraindications to the use of drugs: hypersensitivity, decreased hearing, safety of the drug during pregnancy is not established, lactation.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น